Professor, Internal Medicine, University of Virginia School of Medicine
Nephrology
Dr. Warren K. Bolton, MD
|
|
Give Review
Warren K. Bolton, MD works in the field of Nephrology. He studied medicine at University of Virginia School of Medicine. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Warren K. Bolton, MD is a published doctor. He has 95 papers published. The most current publication "Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Association of Plasma Des-acyl Ghrelin Levels With CKD.
- Referral and Comanagement of the Patient With CKD.
- Editorial: Are men rats? Dendritic cells in autoimmune Glomerulonephritis.
- Phase 1 study of anti-CTGF monoclonal antibody in patients with Diabetes and microalbuminuria.
- Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.
- Potential new therapeutic agents for diabetic Kidney disease.
- T cells and dendritic cells in glomerular Disease: the new glomerulotubular feedback loop.
- Epitope spreading and autoimmune Glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
- Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune Glomerulonephritis in rats.
- Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune Glomerulonephritis in rats.
- Connecting the dots: caring for the patient With progressive CKD.
- Simian T cell leukemia virus type I from naturally infected feral monkeys from central and west Africa encodes a 91-amino acid p12 (ORF-I) protein as opposed to a 99-a...
- Pharmacokinetics of moxalactam in subjects with various degrees of Renal dysfunction.
- New avian model of experimental Glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated Glomerulonephritis in chickens.
- Rapidly progressive silicon Nephropathy.
- Reversible renal Failure from isolated granulomatous renal sarcoidosis.
- Methylprednisolone therapy for Acute crescentic rapidly progressive glomerulonephritis.
- Pharmacokinetics of aztreonam in patients with various degrees of Renal dysfunction.
- Comparison of alternate day steroids and daily steroids in Renal transplant recipients.
- New technique of Kidney tissue processing for immunofluorescence microscopy: formol sucrose/gum sucrose/paraffin.
- Iatrogenic renal Disease.
- Chronic autologous immune complex glomerulopathy: effect of cyproheptadine.
- An evaluation of diabetic and pseudodiabetic glomerulosclerosis.
- Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired Renal function.
- Intravenous pulse methylprednisolone therapy of Acute crescentic rapidly progressive glomerulonephritis.
- Therapy of the idiopathic nephrotic syndrome With alternate day steroids.
- Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
- The prevalence of anemia in patients with chronic Kidney disease.
- Early onset of clinical diabetic Nephropathy in children--a new subgroup?
- Membranous nephropathy: a radioimmunologic search for anti-Renal tubular epithelial antibodies and circulating immune complexes.
- Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. I. Lesions associated With mesangial IgM deposits.
- The effects of normal as compared with low hematocrit values in patients with cardiac Disease who are receiving hemodialysis and epoetin.
- Bovine serum albumin Chronic serum sickness nephropathy in rats.
- Massive proteinuria and Acute renal failure in a patient with Acute silicoproteinosis.
- Renal physicians association clinical practice guideline: appropriate patient preparation for Renal replacement therapy: guideline number 3.
- Heparin skin necrosis: delayed occurrence in a patient on hemodialysis.
- What crit?
- ACE inhibition or angiotensin receptor blockade: impact on potassium in renal Failure. VAL-K Study Group.
- Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
- Study of chemical sympathectomy in endotoxin-induced lethality and fibrin depostion.
- Ventriculojugular shunt nephritis With Corynebacterium bovis. Successful therapy With antibiotics.
- Neuroendocrine alterations in the somatotrophic axis in chronic renal Failure.
- IgA antineutrophil cytoplasmic antibody in Henoch-Schönlein purpura.
- Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. II. Ultrastructural studies.
- Treatment and prognosis of Renal and systemic vasculitis.
- Preparing the patient for Renal replacement therapy. Teamwork optimizes outcomes.
- Analyzing pulsatile endocrine data in patients with chronic renal Failure: a brief review of deconvolution techniques.
- Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with Chronic renal fai...
- Seasons.
- Pulmonary Renal syndrome and emergency therapy.
- Ferumoxytol for the treatment of anemia in chronic Kidney disease.
- Treatment of glomerular Diseases: ANCA-negative RPGN.
- Pathogenesis of focal glomerulosclerosis.
- AutoImmune glomerulotubular nephropathy in mice.
- Adenosine A2A receptor activation attenuates inflammation and injury in diabetic Nephropathy.
- The nature of clinical trials in nephrology.
- Isolation and characterization of chicken mesangial cells.
- Crescentic Glomerulonephritis without immune deposits: clinicopathologic features.
- Transient paralysis of upper extremity after percutaneous cannulation of the subclavian vein for hemodialysis.
- Experimental autoimmune Glomerulonephritis in chickens.
- Ultrastructural studies of experimental autoimmune Glomerulonephritis in normal and bursectomized chickens.
- Requirement of functional T-cells in the production of autoImmune glomerulotubular nephropathy in mice.
- Prospective study of the Immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin.
- Clinical identification of nondiabetic renal Disease in diabetic patients with type I and type II Disease presenting with renal dysfunction.
- Goodpasture's syndrome.
- Pharmacokinetic study of ferumoxytol: a new Iron replacement therapy in normal subjects and hemodialysis patients.
- Use of iohexol to quantify hemodialysis delivered and residual Renal function: technical note.
- Mechanisms of glomerular injury: injury mediated by sensitized lymphocytes.
- Chronic renal insufficiency: current understandings and their implications.
- The role of the nephrologist in ESRD/Pre-ESRD care: a collaborative approach.
- The mortality risk associated With higher hemoglobin: is the therapy to blame?
- Pimagedine: a novel therapy for diabetic Nephropathy.
- Membranoproliferative Glomerulonephritis with primary Sjögren's syndrome.
- Nephrology nurse practitioners in a collaborative care model.
- Rapidly progressive Glomerulonephritis.
- Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel.
- What sensitized cells just might be doing in Glomerulonephritis.
- T-cells and macrophages in rapidly progressive Glomerulonephritis: clinicopathologic correlations.
- Transfer of experimental Glomerulonephritis in chickens by mononuclear cells.
- Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
- The safety and efficacy of ferumoxytol therapy in anemic chronic Kidney disease patients.
- Linear C3 deposits on the tubular basement membrane in Renal allograft biopsies.
- Intravenous iron dextran treatment in predialysis patients with chronic renal Failure.
- Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells.
- Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
- Renal function testing.
- Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 Diabetes and overt nephropathy.
- Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic Nephropathy.
- Proliferative autoimmune Glomerulonephritis in rats: a model for autoimmune Glomerulonephritis in humans.
- Study of EHS type IV collagen lacking Goodpasture's epitope in Glomerulonephritis in rats.
- Molecular mapping of the Goodpasture's epitope for Glomerulonephritis.
- Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane Nephritis in rats.
- Goodpasture's epitope in development of experimental autoimmune Glomerulonephritis in rats.
- A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune Glomerulonephritis.
Schools
Virginia Commonwealth University School Of Medicine
Boston City Hospital
University of Chicago
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute GlomeruloNephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Pathway X Tier Hosp HealthKeepers DirectAccess VA
- HealthKeepers HMO
- KeyCare PPO
- Blue Card PPO
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Golden Rule
- HealthSmart
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- One Net PPO
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
University of Chicago -
University of Virginia School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1003943226 | |
| NPPES Provider LastName | BOLTON | |
| NPPES Provider FirstName | WARREN | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 511.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003943226 |
| Last Name Of The Provider | BOLTON |
| First Name Of The Provider | WARREN |
| View All |
Similar Doctors
|
Dr. Rasheed Balogun, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gayle M. Vranic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas S. Keith, MD |
|
|
Dr. Kambiz Kalantari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir C. Gautam, MD |
|
|
Dr. Joshua D. King, MD |
|
|
Dr. Peter I. Lobo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy J. Mangrum, MD |
|
|
Dr. James R. Freeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary O. Muoneke, MD |